|
Happy New Year!! Holiday Break- No B2DG Meeting on Jan. 1. Next B2DG Mtg is an evening meeting on Jan 8th |
. |
. |
. |
01/01/2013 - 8:30am |
Home with |
|
Biochemistry as programmable nanoscale engineering |
Andrew Hessel |
Distinguished Researcher |
AutoDesk |
01/08/2013 - 6:00pm |
Wilson |
|
Computational Biology Applied to Liver Cells in vitro - High Throughput Screen for Drug Toxicity |
Dr. Mike Bowles |
Founder |
Biomatica |
01/15/2013 - 8:30am |
Sunnyvale |
|
Lean Drug Development Platform |
Madhav Reddy |
President |
Maya Clinicals |
01/22/2013 - 8:30am |
Sunnyvale |
|
Sensors and Methodologies for Wearable Health Monitoring |
Robert Stone, Ph.D. |
Chief Executive Officer |
Medical Design Solutions Inc. |
01/29/2013 - 8:30am |
Sunnyvale |
|
An IRay of Hope: Stereotactic Radiosurgery for the Treatment of Wet AMD. |
Dr. E. Mark Shusterman |
Medical Director |
Oraya Therapeutics, Inc |
02/05/2013 - 8:30am |
Sunnyvale |
|
Biotech Today: An Investor’s Perspective |
Anand Mehra, MD |
Partner |
Sofinnova Ventures |
02/12/2013 - 6:00pm |
Wilson |
|
Bay Area Biomedical Industry: Current Trends and Future Outlook |
Audrey Erbes, Ph.D. |
Principal, |
Erbes and Associates and www.AudreysNetwork.com |
02/19/2013 - 8:30am |
Sunnyvale |
|
“Intellectual Property: It’s a strategy, not a collection ” |
Wouter Roorda |
Consultant, Patent Agent |
. |
02/26/2013 - 8:30am |
Sunnyvale |
|
Starting a Medical Device Company in Silicon Valley |
Michael Allen |
Vascular Designs |
President & CEO |
03/05/2013 - 8:30am |
Sunnyvale |
|
Technology for Pharmacist-Patient Collaboration Improves Adherence & Hospitalization Risk |
David Parpart & Sunit Gala |
Founder |
IMPACTMeds |
03/12/2013 - 6:00pm |
Wilson |
|
Cepheid at the forefront of diagnostic development and what the future holds |
John L. Bishop |
Chairman and Chief Executive Officer |
Cepheid |
03/19/2013 - 8:30am |
Sunnyvale |
|
Medical Reliability Testing |
Mike Silverman |
Founder |
Ops A La Carte |
03/26/2013 - 8:30am |
Sunnyvale |
|
Medical Device Excise Tax – Getting Ready for Your First Quarterly Excise Tax Return |
Ashley Price, Senior Manager & Brian Jenkins, Manager |
National Federal Tax Services |
Deloitte Tax LLP |
04/02/2013 - 8:30am |
Sunnyvale |
|
EVENT IS SOLD OUT---The brave (and economical) new world of medtech innovation |
Paul Yock, M.D. |
Martha Meier Weiland Prof. of Medicine & ME, and Founding Co-Chair of Bioengineering |
Stanford University |
04/09/2013 - 6:00pm |
Wilson |
|
The role of lipid mediators in metabolic disease and malignant tissue growth: two distinct diseases- one common denominator |
Ayala R. Luria, Ph.D. |
Research Scientist |
Scientist Institute for Regenerative Cures |
04/16/2013 - 8:30am |
Sunnyvale |
|
Obesity 360 |
Nat Bowditch, Darshana Nadkarni & Alex Nedvetsky |
|
. |
04/23/2013 - 8:30am |
Sunnyvale |
|
Role of the CDC at Ports of Entry |
Andre Berro, MPH, CPH |
Public Health Advisor |
Center for Disease Control & Prevention |
04/30/2013 - 8:30am |
Sunnyvale |
|
Ring! Ring! FDA Calling! |
Connie Hoy |
Vice President of Regulatory Affairs and Quality Assurance |
Cutera |
05/14/2013 - 6:00pm |
Wilson |
|
Know Your Options: Implementation of Virtual Commercial Operations |
Linda L. Schock |
Director, Commercial Compliance and Government Programs |
CIS Compliance Implementation Services |
05/21/2013 - 8:30am |
Sunnyvale |
|
New Treatments for Obstructive Sleep Apnea |
Nat Bowditch |
|
Apneon |
05/28/2013 - 8:30am |
Sunnyvale |
|
Will Medical Devices Survive the Headwinds of Change in the new Healthcare Ecosystem |
Reenita Das |
Partner |
Frost & Sullivan |
06/04/2013 - 8:30am |
Sunnyvale |
|
Digital Pathology |
Syed Zafar Hamdani |
President and CEO |
XStor Medical Systems |
06/11/2013 - 6:00pm |
Wilson |
|
Hypertension: A historical and philosophical perspective |
Michel Accad. M.D. |
|
Physician, UCSF |
06/18/2013 - 8:30am |
Sunnyvale |
|
A brief history of how one company helped pioneer a novel therapy and a new wave of innovati |
Ben Clark |
Engineering Manager |
Medtronic/Ardian |
06/25/2013 - 8:30am |
Sunnyvale |
|
Aesthetics: A Novel Business Model for Regenerative Medicine |
Gail Naughton |
Founder & CEO |
Histogen, Inc. |
11/12/2013 - 6:00pm |
Wilson |